Global 3D Bio-printing Market research and Analysis, 2015-2022
Market Insights
The 3D bioprinting market is anticipated to witness an impressive growth rate during the forecasted period. According to analysts’ estimate the 3D bioprinting market is expected to grow impressively with a CAGR of 17.3% during 2016-2022. The pivotal factors contributing in the growth of 3D Bioprinting Market includes rising incidences of life style oriented diseases, massive demand for organ & tissue transplants and improvement in life expectancy rate. Approximately, 17,107 kidney transplants took place in 2014 in the U.S. while the mortality rate is around 13 individuals per day while waiting for a kidney transplant. Limited number of organ donors has also attributed towards the growth of the 3D bioprinting market. According to U.S. Department of Health & Human Services, in every 10 min. an individual is added to the national transplant waiting list. The growth in the waiting list of transplants has created a potential for the 3D bioprinted implants and organs.
Technological advancements and integration of IT in the healthcare sector and enhancing R&D efforts for the industry are likely to act as high impact rendering drivers for the global 3D bioprinting market. Increasing geriatric population base is also seen as one of the major booster to the growth within the 3D bioprinting market during the research. According to Helpage.org in 2015, around 12.3% of the global population is of age group 60 and above, which is expected to reach 16.5% by the end of 2030. Emerging medical applications of 3D bioprinting such as drug discovery, consumer producttesting, toxicity testing and tissue engineering are anticipated to further drive the growth of the global market positively. However, lack of skilled professionals is anticipated to hamper the growth of the global 3D bioprinting market.
Geographical Insights
The global 3D bioprinting market can be geographically segregated into Europe, North America, Asia Pacific and RoW. In current scenario, North America dominates the global 3D bioprinting market in terms of revenue. In 2014, the region held the market share of around 35%. Rise in life style oriented diseases and growth in geriatric population along with reasonably higher patient disposable income and sophisticated healthcare infrastructure are the key drivers for the regional market. Moreover, extensive research activities are being conducted within the region which is anticipated to be a vital growth factor during the forecasted period. In 2015, at the AHASS (American Heart Association Scientific Sessions), the Wake Forest University of North Carolina presented their research study related to the development of the personalized medication. The pills will be designed as per the biological profile of each patient which includes weight, organ function capacity, race and gender.
Furthermore, APAC region is anticipated to be fastest growing region mainly due to significant adaptation of technological advancements and pioneering presence in the development of healthcare IT. The supportive government initiatives, rising awareness level and increasing foreign investments within the region for the research purpose is anticipated to propel the market growth over the projected period.
The report includes detailed market overview, market determinants, company profiling, sector analysis, market segmentation, geographical analysis, patent analysis, strategic recommendations, key company analysis, key findings, market estimations, market insights, analyst insights and predictive analysis of the market.
Competitive Insights
Key players of 3D bioprinting market include Cyfuse Biomedical, Organovo Holding Inc., Luxexcel Group BV, BioBots, Aspect Biosystems, Stratasys Ltd., and 3Dynamics Systems. The market palyers are adopting the strategy of tie-ups with universities and research institutes that work on grafting as well as organ regeneration technologies. In 2015, Organovo Holding Inc. participated in Cantor Fitzgerald Inaugural Healthcare Conference with the aim to increase awareness related to their current activities in 3D bioprinting market. The other key strategy which was adopted by market players during 2015 is product launch. In 2015, Biobots Inc. launched its premier 3D bioprinter named BioBot 1. This bioprinter possess the capability of printing functional 3D constructs from living cells.This device is expected to put the 3D bioprinting technology within the hands of more researchers across the globe by considerably lowering the technical expertise as well as cost that is required to operate the similar kind of devices in the past.
Market Segmentation:
The 3D bioprinting market is anticipated to witness an impressive growth rate during the forecasted period. According to analysts’ estimate the 3D bioprinting market is expected to grow impressively with a CAGR of 17.3% during 2016-2022. The pivotal factors contributing in the growth of 3D Bioprinting Market includes rising incidences of life style oriented diseases, massive demand for organ & tissue transplants and improvement in life expectancy rate. Approximately, 17,107 kidney transplants took place in 2014 in the U.S. while the mortality rate is around 13 individuals per day while waiting for a kidney transplant. Limited number of organ donors has also attributed towards the growth of the 3D bioprinting market. According to U.S. Department of Health & Human Services, in every 10 min. an individual is added to the national transplant waiting list. The growth in the waiting list of transplants has created a potential for the 3D bioprinted implants and organs.
Technological advancements and integration of IT in the healthcare sector and enhancing R&D efforts for the industry are likely to act as high impact rendering drivers for the global 3D bioprinting market. Increasing geriatric population base is also seen as one of the major booster to the growth within the 3D bioprinting market during the research. According to Helpage.org in 2015, around 12.3% of the global population is of age group 60 and above, which is expected to reach 16.5% by the end of 2030. Emerging medical applications of 3D bioprinting such as drug discovery, consumer producttesting, toxicity testing and tissue engineering are anticipated to further drive the growth of the global market positively. However, lack of skilled professionals is anticipated to hamper the growth of the global 3D bioprinting market.
Geographical Insights
The global 3D bioprinting market can be geographically segregated into Europe, North America, Asia Pacific and RoW. In current scenario, North America dominates the global 3D bioprinting market in terms of revenue. In 2014, the region held the market share of around 35%. Rise in life style oriented diseases and growth in geriatric population along with reasonably higher patient disposable income and sophisticated healthcare infrastructure are the key drivers for the regional market. Moreover, extensive research activities are being conducted within the region which is anticipated to be a vital growth factor during the forecasted period. In 2015, at the AHASS (American Heart Association Scientific Sessions), the Wake Forest University of North Carolina presented their research study related to the development of the personalized medication. The pills will be designed as per the biological profile of each patient which includes weight, organ function capacity, race and gender.
Furthermore, APAC region is anticipated to be fastest growing region mainly due to significant adaptation of technological advancements and pioneering presence in the development of healthcare IT. The supportive government initiatives, rising awareness level and increasing foreign investments within the region for the research purpose is anticipated to propel the market growth over the projected period.
The report includes detailed market overview, market determinants, company profiling, sector analysis, market segmentation, geographical analysis, patent analysis, strategic recommendations, key company analysis, key findings, market estimations, market insights, analyst insights and predictive analysis of the market.
Competitive Insights
Key players of 3D bioprinting market include Cyfuse Biomedical, Organovo Holding Inc., Luxexcel Group BV, BioBots, Aspect Biosystems, Stratasys Ltd., and 3Dynamics Systems. The market palyers are adopting the strategy of tie-ups with universities and research institutes that work on grafting as well as organ regeneration technologies. In 2015, Organovo Holding Inc. participated in Cantor Fitzgerald Inaugural Healthcare Conference with the aim to increase awareness related to their current activities in 3D bioprinting market. The other key strategy which was adopted by market players during 2015 is product launch. In 2015, Biobots Inc. launched its premier 3D bioprinter named BioBot 1. This bioprinter possess the capability of printing functional 3D constructs from living cells.This device is expected to put the 3D bioprinting technology within the hands of more researchers across the globe by considerably lowering the technical expertise as well as cost that is required to operate the similar kind of devices in the past.
Market Segmentation:
- 3d BioprintingMarket by Technology
- Magnetic Levitation
- Syringe Based
- Laser Assisted
- Inkjet Based
- Valve-Based
- 3d Bioprinting Market by Application
- Medical
- Bioinks
- Dental
- Food and Animal Product
- Biosensors
- Consumer/Personal Product Testing
- Comprehensive research methodology of global 3D Bioprinting market
- In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global 3D Bioprinting market
- Insights about market determinants which are stimulating the global 3D Bioprinting market
- Detailed and extensive market segments with regional distribution of researched revenues
- Extensive profiles and recent developments of market players
1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
2.3. REGULATIONS
2.3.1. UNITED STATES
2.3.2. EUROPEAN UNION
2.3.3. CHINA
2.3.4. INDIA
2.3.5. REST OF THE WORLD
2.4. PATENT ANALYSIS
3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. INCREASING INCIDENCES OF CHRONIC ILLNESSES
3.1.2. LIMITED NUMBER OF ORGAN DONORS
3.1.3. INCREASING LIFE SPAN OF HUMAN BEINGS
3.1.4. INTEGRATION OF IT WITHIN HEALTHCARE INDUSTRY
3.1.5. GROWING GERIATRIC POPULATION
3.1.6. IMPROVING EFFORTS IN R&D
3.1.7. RISING DEMAND FOR ORGAN TRANSPLANTS
3.2. RESTRAINTS
3.2.1. HIGH COST OF BIOPRINTERS
3.2.2. LIMITED TYPE OF MATERIAL AVAILABILITY
3.2.3. LACK OF SKILLED PROFESSIONALS
3.2.4. LACK OF REIMBURSEMENT POLICIES
3.3. OPPORTUNITIES
3.3.1. TECHNOLOGICAL ADVANCEMENTS
3.3.2. RISING NEED FOR PERSONALIZED MEDICINE
3.3.3. GROWING MEDICAL TOURISM IN EMERGING ECONOMIES
4. MARKET SEGMENTATION
4.1. 3D BIOPRINTING MARKET BY TECHNOLOGY
4.1.1. MAGNETIC LEVITATION
4.1.2. SYRINGE BASED
4.1.3. LASER ASSISTED
4.1.4. INKJET BASED
4.1.5. VALVE-BASED
4.2. 3D BIOPRINTING
4.2.1. MEDICAL
4.2.2. BIOINKS
4.2.3. DENTAL
4.2.4. FOOD AND ANIMAL PRODUCT
4.2.5. BIOSENSORS
4.2.6. CONSUMER/PERSONAL PRODUCT TESTING
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.2. KEY COMPANY ANALYSIS
6. REGIONAL ANALYSIS
6.1. NORTH AMERICA
6.1.1. UNITED STATES
6.1.2. CANADA
6.1.3. REST OF NORTH AMERICA
6.2. EUROPE
6.2.1. UNITED KINGDOM
6.2.2. FRANCE
6.2.3. GERMANY
6.2.4. ITALY
6.2.5. SPAIN
6.2.6. REST OF EUROPE
6.3. ASIA PACIFIC
6.3.1. INDIA
6.3.2. CHINA
6.3.3. JAPAN
6.4. REST OF THE WORLD
7. COMPANY PROFILES
7.1. ADVANCED BIOMATRIX
7.1.1. INTRODUCTION
7.1.2. ADVANCED BIOMATRIX PRODUCT PORTFOLIO
7.1.3. ADVANCED BIOMATRIX RECENT ACTIVITIES
7.2. ASPECT BIOSYSTEMS
7.2.1. INTRODUCTION
7.2.2. ASPECT BIOSYSTEMS PRODUCT PORTFOLIO
7.2.3. ASPECT BIOSYSTEMS RECENT ACTIVITIES
7.3. BESPOKE INNOVATIONS
7.3.1. INTRODUCTION
7.3.2. BESPOKE INNOVATIONS PRODUCT PORTFOLIO
7.3.3. BESPOKE INNOVATIONS RECENT ACTIVITIES
7.4. BIOBOTS
7.4.1. INTRODUCTION
7.4.2. BIOBOTS PRODUCT PORTFOLIO
7.4.3. BIOBOTS RECENT ACTIVITIES
7.5. BIO3D TECHNOLOGIES
7.5.1. INTRODUCTION
7.5.2. BIO3D TECHNOLOGIES PRODUCT PORTFOLIO
7.5.3. BIO3D TECHNOLOGIES RECENT ACTIVITIES
7.6. CMC MICROSYSTEMS
7.6.1. INTRODUCTION
7.6.2. CMC MICROSYSTEMS PRODUCT PORTFOLIO
7.6.3. CMC MICROSYSTEMS RECENT ACTIVITIES
7.7. CYFUSE BIOMEDICAL
7.7.1. INTRODUCTION
7.7.2. CYFUSE BIOMEDICAL PRODUCT PORTFOLIO
7.7.3. CYFUSE BIOMEDICAL RECENT ACTIVITIES
7.8. DIGILAB
7.8.1. INTRODUCTION
7.8.2. DIGILAB PRODUCT PORTFOLIO
7.8.3. DIGILAB RECENT ACTIVITIES
7.9. 3D BIOTEK
7.9.1. INTRODUCTION
7.9.2. 3D BIOTEK PRODUCT PORTFOLIO
7.9.3. 3D BIOTEK RECENT ACTIVITIES
7.10. 3DYNAMICS SYSTEMS
7.10.1. INTRODUCTION
7.10.2. 3DYNAMICS SYSTEMS PRODUCT PORTFOLIO
7.10.3. 3DYNAMICS SYSTEMS RECENT ACTIVITIES
7.11. ENVISION TEC
7.11.1. INTRODUCTION
7.11.2. ENVISION TEC PRODUCT PORTFOLIO
7.11.3. ENVISION TEC RECENT ACTIVITIES
7.12. LUXEXCEL GROUP BV
7.12.1. INTRODUCTION
7.12.2. LUXEXCEL GROUP BV PRODUCT PORTFOLIO
7.12.3. LUXEXCEL GROUP BV RECENT ACTIVITIES
7.13. MATERIALISE NV
7.13.1. INTRODUCTION
7.13.2. MATERIALISE NV PRODUCT PORTFOLIO
7.13.3. MATERIALISE NV RECENT ACTIVITIES
7.14. OCEANZ
7.14.1. INTRODUCTION
7.14.2. OCEANZ PRODUCT PORTFOLIO
7.14.3. OCEANZ RECENT ACTIVITIES
7.15. ORGANOVO HOLDING INC.
7.15.1. INTRODUCTION
7.15.2. ORGANOVO HOLDING INC. PRODUCT PORTFOLIO
7.15.3. ORGANOVO HOLDING INC. RECENT ACTIVITIES
7.16. SOLIDSCAPE
7.16.1. INTRODUCTION
7.16.2. SOLIDSCAPE PRODUCT PORTFOLIO
7.16.3. SOLIDSCAPE RECENT ACTIVITIES
7.17. STRATASYS LTD.
7.17.1. INTRODUCTION
7.17.2. STRATASYS LTD. PRODUCT PORTFOLIO
7.17.3. STRATASYS LTD. RECENT ACTIVITIES
7.18. TEVIDO BIODEVICES
7.18.1. INTRODUCTION
7.18.2. TEVIDO BIODEVICES PRODUCT PORTFOLIO
7.18.3. TEVIDO BIODEVICES RECENT ACTIVITIES
7.19. UNITED THERAPEUTICS
7.19.1. INTRODUCTION
7.19.2. UNITED THERAPEUTICS PRODUCT PORTFOLIO
7.19.3. UNITED THERAPEUTICS RECENT ACTIVITIES
7.20. VOXELJET
7.20.1. INTRODUCTION
7.20.2. VOXELJET PRODUCT PORTFOLIO
7.20.3. VOXELJET RECENT ACTIVITIES
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
2.3. REGULATIONS
2.3.1. UNITED STATES
2.3.2. EUROPEAN UNION
2.3.3. CHINA
2.3.4. INDIA
2.3.5. REST OF THE WORLD
2.4. PATENT ANALYSIS
3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. INCREASING INCIDENCES OF CHRONIC ILLNESSES
3.1.2. LIMITED NUMBER OF ORGAN DONORS
3.1.3. INCREASING LIFE SPAN OF HUMAN BEINGS
3.1.4. INTEGRATION OF IT WITHIN HEALTHCARE INDUSTRY
3.1.5. GROWING GERIATRIC POPULATION
3.1.6. IMPROVING EFFORTS IN R&D
3.1.7. RISING DEMAND FOR ORGAN TRANSPLANTS
3.2. RESTRAINTS
3.2.1. HIGH COST OF BIOPRINTERS
3.2.2. LIMITED TYPE OF MATERIAL AVAILABILITY
3.2.3. LACK OF SKILLED PROFESSIONALS
3.2.4. LACK OF REIMBURSEMENT POLICIES
3.3. OPPORTUNITIES
3.3.1. TECHNOLOGICAL ADVANCEMENTS
3.3.2. RISING NEED FOR PERSONALIZED MEDICINE
3.3.3. GROWING MEDICAL TOURISM IN EMERGING ECONOMIES
4. MARKET SEGMENTATION
4.1. 3D BIOPRINTING MARKET BY TECHNOLOGY
4.1.1. MAGNETIC LEVITATION
4.1.2. SYRINGE BASED
4.1.3. LASER ASSISTED
4.1.4. INKJET BASED
4.1.5. VALVE-BASED
4.2. 3D BIOPRINTING
4.2.1. MEDICAL
4.2.2. BIOINKS
4.2.3. DENTAL
4.2.4. FOOD AND ANIMAL PRODUCT
4.2.5. BIOSENSORS
4.2.6. CONSUMER/PERSONAL PRODUCT TESTING
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.2. KEY COMPANY ANALYSIS
6. REGIONAL ANALYSIS
6.1. NORTH AMERICA
6.1.1. UNITED STATES
6.1.2. CANADA
6.1.3. REST OF NORTH AMERICA
6.2. EUROPE
6.2.1. UNITED KINGDOM
6.2.2. FRANCE
6.2.3. GERMANY
6.2.4. ITALY
6.2.5. SPAIN
6.2.6. REST OF EUROPE
6.3. ASIA PACIFIC
6.3.1. INDIA
6.3.2. CHINA
6.3.3. JAPAN
6.4. REST OF THE WORLD
7. COMPANY PROFILES
7.1. ADVANCED BIOMATRIX
7.1.1. INTRODUCTION
7.1.2. ADVANCED BIOMATRIX PRODUCT PORTFOLIO
7.1.3. ADVANCED BIOMATRIX RECENT ACTIVITIES
7.2. ASPECT BIOSYSTEMS
7.2.1. INTRODUCTION
7.2.2. ASPECT BIOSYSTEMS PRODUCT PORTFOLIO
7.2.3. ASPECT BIOSYSTEMS RECENT ACTIVITIES
7.3. BESPOKE INNOVATIONS
7.3.1. INTRODUCTION
7.3.2. BESPOKE INNOVATIONS PRODUCT PORTFOLIO
7.3.3. BESPOKE INNOVATIONS RECENT ACTIVITIES
7.4. BIOBOTS
7.4.1. INTRODUCTION
7.4.2. BIOBOTS PRODUCT PORTFOLIO
7.4.3. BIOBOTS RECENT ACTIVITIES
7.5. BIO3D TECHNOLOGIES
7.5.1. INTRODUCTION
7.5.2. BIO3D TECHNOLOGIES PRODUCT PORTFOLIO
7.5.3. BIO3D TECHNOLOGIES RECENT ACTIVITIES
7.6. CMC MICROSYSTEMS
7.6.1. INTRODUCTION
7.6.2. CMC MICROSYSTEMS PRODUCT PORTFOLIO
7.6.3. CMC MICROSYSTEMS RECENT ACTIVITIES
7.7. CYFUSE BIOMEDICAL
7.7.1. INTRODUCTION
7.7.2. CYFUSE BIOMEDICAL PRODUCT PORTFOLIO
7.7.3. CYFUSE BIOMEDICAL RECENT ACTIVITIES
7.8. DIGILAB
7.8.1. INTRODUCTION
7.8.2. DIGILAB PRODUCT PORTFOLIO
7.8.3. DIGILAB RECENT ACTIVITIES
7.9. 3D BIOTEK
7.9.1. INTRODUCTION
7.9.2. 3D BIOTEK PRODUCT PORTFOLIO
7.9.3. 3D BIOTEK RECENT ACTIVITIES
7.10. 3DYNAMICS SYSTEMS
7.10.1. INTRODUCTION
7.10.2. 3DYNAMICS SYSTEMS PRODUCT PORTFOLIO
7.10.3. 3DYNAMICS SYSTEMS RECENT ACTIVITIES
7.11. ENVISION TEC
7.11.1. INTRODUCTION
7.11.2. ENVISION TEC PRODUCT PORTFOLIO
7.11.3. ENVISION TEC RECENT ACTIVITIES
7.12. LUXEXCEL GROUP BV
7.12.1. INTRODUCTION
7.12.2. LUXEXCEL GROUP BV PRODUCT PORTFOLIO
7.12.3. LUXEXCEL GROUP BV RECENT ACTIVITIES
7.13. MATERIALISE NV
7.13.1. INTRODUCTION
7.13.2. MATERIALISE NV PRODUCT PORTFOLIO
7.13.3. MATERIALISE NV RECENT ACTIVITIES
7.14. OCEANZ
7.14.1. INTRODUCTION
7.14.2. OCEANZ PRODUCT PORTFOLIO
7.14.3. OCEANZ RECENT ACTIVITIES
7.15. ORGANOVO HOLDING INC.
7.15.1. INTRODUCTION
7.15.2. ORGANOVO HOLDING INC. PRODUCT PORTFOLIO
7.15.3. ORGANOVO HOLDING INC. RECENT ACTIVITIES
7.16. SOLIDSCAPE
7.16.1. INTRODUCTION
7.16.2. SOLIDSCAPE PRODUCT PORTFOLIO
7.16.3. SOLIDSCAPE RECENT ACTIVITIES
7.17. STRATASYS LTD.
7.17.1. INTRODUCTION
7.17.2. STRATASYS LTD. PRODUCT PORTFOLIO
7.17.3. STRATASYS LTD. RECENT ACTIVITIES
7.18. TEVIDO BIODEVICES
7.18.1. INTRODUCTION
7.18.2. TEVIDO BIODEVICES PRODUCT PORTFOLIO
7.18.3. TEVIDO BIODEVICES RECENT ACTIVITIES
7.19. UNITED THERAPEUTICS
7.19.1. INTRODUCTION
7.19.2. UNITED THERAPEUTICS PRODUCT PORTFOLIO
7.19.3. UNITED THERAPEUTICS RECENT ACTIVITIES
7.20. VOXELJET
7.20.1. INTRODUCTION
7.20.2. VOXELJET PRODUCT PORTFOLIO
7.20.3. VOXELJET RECENT ACTIVITIES
LIST OF TABLES
Table # 1 GLOBAL 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS, BY TECHNOLOGY 2015-2022 ($ MILLION)
Table # 2 GLOBAL MAGNETIC LEVITATION MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 3 GLOBAL SYRINGE BASED 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 4 GLOBAL LASER ASSISTED 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 5 GLOBAL INKJET BASED 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 6 GLOBAL VALVE-BASED 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 7 GLOBAL 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS, BY APPLICATION 2015-2022 ($ MILLION)
Table # 8 GLOBAL MEDICAL MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Table # 9 GLOBAL BIOINKS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Table # 10 GLOBAL DENTAL MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Table # 11 GLOBAL FOOD AND ANIMAL PRODUCT MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Table # 12 GLOBAL BIOSENSORS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Table # 13 GLOBAL CONSUMER/PERSONAL PRODUCT TESTING MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Table # 14 ADVANCED BIOMATRIX PRODUCT PORTFOLIO
Table # 15 ADVANCED BIOMATRIX RECENT ACTIVITIES
Table # 16 ASPECT BIOSYSTEMS PRODUCT PORTFOLIO
Table # 17 ASPECT BIOSYSTEMS RECENT ACTIVITIES
Table # 18 BESPOKE INNOVATIONS PRODUCT PORTFOLIO
Table # 19 BESPOKE INNOVATIONS RECENT ACTIVITIES
Table # 20 BIOBOTS PRODUCT PORTFOLIO
Table # 21 BIOBOTS RECENT ACTIVITIES
Table # 22 BIO3D TECHNOLOGIES PRODUCT PORTFOLIO
Table # 23 BIO3D TECHNOLOGIES RECENT ACTIVITIES
Table # 24 CMC MICROSYSTEMS PRODUCT PORTFOLIO
Table # 25 CMC MICROSYSTEMS RECENT ACTIVITIES
Table # 26 CYFUSE BIOMEDICAL PRODUCT PORTFOLIO
Table # 27 CYFUSE BIOMEDICAL RECENT ACTIVITIES
Table # 28 DIGILAB PRODUCT PORTFOLIO
Table # 29 DIGILAB RECENT ACTIVITIES
Table # 30 3D BIOTEK PRODUCT PORTFOLIO
Table # 31 3D BIOTEK RECENT ACTIVITIES
Table # 32 3DYNAMICS SYSTEMS PRODUCT PORTFOLIO
Table # 33 3DYNAMICS SYSTEMS RECENT ACTIVITIES
Table # 34 ENVISION TEC PRODUCT PORTFOLIO
Table # 35 ENVISION TEC RECENT ACTIVITIES
Table # 36 LUXEXCEL GROUP BV PRODUCT PORTFOLIO
Table # 37 LUXEXCEL GROUP BV RECENT ACTIVITIES
Table # 38 MATERIALISE NV PRODUCT PORTFOLIO
Table # 39 MATERIALISE NV RECENT ACTIVITIES
Table # 40 OCEANZ PRODUCT PORTFOLIO
Table # 41 OCEANZ RECENT ACTIVITIES
Table # 42 ORGANOVO HOLDING INC.PRODUCT PORTFOLIO
Table # 43 ORGANOVO HOLDING INC.RECENT ACTIVITIES
Table # 44 SOLIDSCAPE PRODUCT PORTFOLIO
Table # 45 SOLIDSCAPE RECENT ACTIVITIES
Table # 46 STRATASYS LTD.PRODUCT PORTFOLIO
Table # 47 STRATASYS LTD.RECENT ACTIVITIES
Table # 48 TEVIDO BIODEVICES PRODUCT PORTFOLIO
Table # 49 TEVIDO BIODEVICES RECENT ACTIVITIES
Table # 50 UNITED THERAPEUTICS PRODUCT PORTFOLIO
Table # 51 UNITED THERAPEUTICS RECENT ACTIVITIES
Table # 52 VOXELJET PRODUCT PORTFOLIO
Table # 53 VOXELJET RECENT ACTIVITIES
Table # 1 GLOBAL 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS, BY TECHNOLOGY 2015-2022 ($ MILLION)
Table # 2 GLOBAL MAGNETIC LEVITATION MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 3 GLOBAL SYRINGE BASED 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 4 GLOBAL LASER ASSISTED 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 5 GLOBAL INKJET BASED 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 6 GLOBAL VALVE-BASED 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 7 GLOBAL 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS, BY APPLICATION 2015-2022 ($ MILLION)
Table # 8 GLOBAL MEDICAL MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Table # 9 GLOBAL BIOINKS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Table # 10 GLOBAL DENTAL MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Table # 11 GLOBAL FOOD AND ANIMAL PRODUCT MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Table # 12 GLOBAL BIOSENSORS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Table # 13 GLOBAL CONSUMER/PERSONAL PRODUCT TESTING MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Table # 14 ADVANCED BIOMATRIX PRODUCT PORTFOLIO
Table # 15 ADVANCED BIOMATRIX RECENT ACTIVITIES
Table # 16 ASPECT BIOSYSTEMS PRODUCT PORTFOLIO
Table # 17 ASPECT BIOSYSTEMS RECENT ACTIVITIES
Table # 18 BESPOKE INNOVATIONS PRODUCT PORTFOLIO
Table # 19 BESPOKE INNOVATIONS RECENT ACTIVITIES
Table # 20 BIOBOTS PRODUCT PORTFOLIO
Table # 21 BIOBOTS RECENT ACTIVITIES
Table # 22 BIO3D TECHNOLOGIES PRODUCT PORTFOLIO
Table # 23 BIO3D TECHNOLOGIES RECENT ACTIVITIES
Table # 24 CMC MICROSYSTEMS PRODUCT PORTFOLIO
Table # 25 CMC MICROSYSTEMS RECENT ACTIVITIES
Table # 26 CYFUSE BIOMEDICAL PRODUCT PORTFOLIO
Table # 27 CYFUSE BIOMEDICAL RECENT ACTIVITIES
Table # 28 DIGILAB PRODUCT PORTFOLIO
Table # 29 DIGILAB RECENT ACTIVITIES
Table # 30 3D BIOTEK PRODUCT PORTFOLIO
Table # 31 3D BIOTEK RECENT ACTIVITIES
Table # 32 3DYNAMICS SYSTEMS PRODUCT PORTFOLIO
Table # 33 3DYNAMICS SYSTEMS RECENT ACTIVITIES
Table # 34 ENVISION TEC PRODUCT PORTFOLIO
Table # 35 ENVISION TEC RECENT ACTIVITIES
Table # 36 LUXEXCEL GROUP BV PRODUCT PORTFOLIO
Table # 37 LUXEXCEL GROUP BV RECENT ACTIVITIES
Table # 38 MATERIALISE NV PRODUCT PORTFOLIO
Table # 39 MATERIALISE NV RECENT ACTIVITIES
Table # 40 OCEANZ PRODUCT PORTFOLIO
Table # 41 OCEANZ RECENT ACTIVITIES
Table # 42 ORGANOVO HOLDING INC.PRODUCT PORTFOLIO
Table # 43 ORGANOVO HOLDING INC.RECENT ACTIVITIES
Table # 44 SOLIDSCAPE PRODUCT PORTFOLIO
Table # 45 SOLIDSCAPE RECENT ACTIVITIES
Table # 46 STRATASYS LTD.PRODUCT PORTFOLIO
Table # 47 STRATASYS LTD.RECENT ACTIVITIES
Table # 48 TEVIDO BIODEVICES PRODUCT PORTFOLIO
Table # 49 TEVIDO BIODEVICES RECENT ACTIVITIES
Table # 50 UNITED THERAPEUTICS PRODUCT PORTFOLIO
Table # 51 UNITED THERAPEUTICS RECENT ACTIVITIES
Table # 52 VOXELJET PRODUCT PORTFOLIO
Table # 53 VOXELJET RECENT ACTIVITIES
LIST OF FIGURES
Figure # 1 NORTH AMERICA MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 2 US MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 3 CANADA MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 5 UK MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 6 FRANCE MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 7 GERMANY MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 8 ITALY MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 9 SPAIN MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 10 ROE MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 11 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 12 INDIA MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 13 CHINA MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 14 JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 15 ROPAC MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 16 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 1 NORTH AMERICA MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 2 US MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 3 CANADA MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 5 UK MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 6 FRANCE MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 7 GERMANY MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 8 ITALY MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 9 SPAIN MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 10 ROE MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 11 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 12 INDIA MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 13 CHINA MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 14 JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 15 ROPAC MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 16 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2022
